Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| LUNG | Radhakrishnan Srikanth | Chief Science & Techn. Officer | 09/01/2026 | Verkauf | 2.26 | 2,643 | 5,973 | Form 4 |
| LUNG | French Glendon E. III | President and CEO | 09/01/2026 | Verkauf | 2.26 | 37,784 | 85,392 | Form 4 |
| LUNG | French Glendon E. III | President and CEO | 09/01/2026 | Verkauf | 2.26 | 4,098 | 9,261 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 09/01/2026 | Verkauf | 2.26 | 1,746 | 3,946 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 09/01/2026 | Verkauf | 2.26 | 1,530 | 3,458 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 09/01/2026 | Verkauf | 2.26 | 2,390 | 5,401 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 09/01/2026 | Verkauf | 2.26 | 2,213 | 5,001 | Form 4 |
| LUNG | Lehman David Aaron | General Counsel | 09/01/2026 | Verkauf | 2.26 | 4,827 | 10,909 | Form 4 |
| LUNG | Lehman David Aaron | General Counsel | 09/01/2026 | Verkauf | 2.26 | 3,476 | 7,856 | Form 4 |
| LUNG | Lehman David Aaron | General Counsel | 09/01/2026 | Verkauf | 2.26 | 2,224 | 5,026 | Form 4 |
| LUNG | Lehman David Aaron | General Counsel | 09/01/2026 | Verkauf | 2.26 | 3,807 | 8,604 | Form 4 |
| POST | Stiritz William P | Chairman Emeritus | 09/01/2026 | Verkauf | 84.63 | 6,207 | 525,298 | Form 4 |
| POST | Stiritz William P | Chairman Emeritus | 09/01/2026 | Verkauf | 83.54 | 99,990 | 8,353,165 | Form 4 |
| PLBY | Edmonds Tracey E | Director | 09/01/2026 | Verkauf | 1.18 | 4,283 | 5,043 | Form 4 |
| CATX | Lantheus Holdings, Inc. | 10% Owner | 09/01/2026 | Verkauf | 3.12 | 35,769 | 111,574 | Form 4 |
| PANW | Paul Josh D. | Chief Accounting Officer | 09/01/2026 | Verkauf | 373.68 | 900 | 336,312 | Form 4 |
| PLTR | Stat Lauren Elaina Friedman | Director | 09/01/2026 | Verkauf | 182.50 | 1,342 | 244,915 | Form 4 |
| PCOR | O Connor Kevin J | Director | 09/01/2026 | Verkauf | 62.38 | 2,398 | 149,587 | Form 4 |
| PCOR | O Connor Kevin J | Director | 09/01/2026 | Verkauf | 61.87 | 5,294 | 327,540 | Form 4 |
| CNXN | Gallup Patricia | Chairman & Chief Admin Officer | 09/01/2026 | Verkauf | 79.39 | 2,270 | 180,215 | Form 4 |
| CNXN | Gallup Patricia | Chairman & Chief Admin Officer | 09/01/2026 | Verkauf | 78.76 | 4,872 | 383,719 | Form 4 |
| PTEN | Drummond Robert Wayne Jr | Director | 09/01/2026 | Verkauf | 12.85 | 1,605 | 20,624 | Form 4 |
| PTEN | Wexler Seth David | EVP, General Counsel&Secretary | 09/01/2026 | Verkauf | 12.75 | 120,000 | 1,530,000 | Form 4 |
| PACS | Murray Jason Hulse | Co-Founder, CEO & Chairman | 09/01/2026 | Verkauf | 43.05 | 1,368 | 58,890 | Form 4 |
| PACS | Murray Jason Hulse | Co-Founder, CEO & Chairman | 09/01/2026 | Verkauf | 42.35 | 22,789 | 965,157 | Form 4 |
| OFIX | Fisher Patrick | President, Global Limb Recon | 09/01/2026 | Verkauf | 9.39 | 150 | 1,409 | Form 4 |
| OMDA | Duffy Sean P. | Chief Executive Officer | 09/01/2026 | Verkauf | 24.27 | 3,695 | 89,682 | Form 4 |
| OMDA | Duffy Sean P. | Chief Executive Officer | 09/01/2026 | Verkauf | 23.13 | 4,933 | 114,100 | Form 4 |
| OMDA | Duffy Sean P. | Chief Executive Officer | 09/01/2026 | Verkauf | 24.27 | 5,600 | 135,901 | Form 4 |
| OMDA | Duffy Sean P. | Chief Executive Officer | 09/01/2026 | Verkauf | 23.12 | 7,344 | 169,782 | Form 4 |
| OKLO | Renner Alexandra | Chief Product Officer | 09/01/2026 | Verkauf | 38.40 | 1,930 | 74,112 | Form 4 |
| OKLO | Bealmear Richard Craig | Chief Financial Officer | 09/01/2026 | Verkauf | 38.76 | 16,430 | 636,827 | Form 4 |
| ODD | Drucker Mann Lindsay | Global Chief Financial Officer | 09/01/2026 | Verkauf | 15.09 | 7,717 | 116,450 | Form 4 |
| OOMA | Hamamatsu Shigeyuki | SVP & Chief Financial Officer | 09/01/2026 | Verkauf | 22.33 | 4,807 | 107,340 | Form 4 |
| ORI | Monroe Carolyn | SVP - Title Insurance | 09/01/2026 | Verkauf | 42.01 | 4,386 | 184,256 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 09/01/2026 | Verkauf | 321.91 | 600 | 193,144 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 09/01/2026 | Verkauf | 320.92 | 1,400 | 449,292 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 09/01/2026 | Verkauf | 319.76 | 1,000 | 319,758 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 09/01/2026 | Verkauf | 320.99 | 1,698 | 545,041 | Form 4 |
| NNE | Yu Jiang | President and Chairman | 09/01/2026 | Verkauf | 17.45 | 332,569 | 5,801,799 | Form 4 |
| NNE | Walker James John | Chief Executive Officer | 09/01/2026 | Verkauf | 17.44 | 25,000 | 436,065 | Form 4 |
| NEM | Viljoen Natascha | President & CEO | 09/01/2026 | Verkauf | 123.00 | 3,882 | 477,486 | Form 4 |
| NEM | Toth Peter | EVP, Chief Sustain & Dev Off | 09/01/2026 | Verkauf | 123.00 | 3,000 | 369,000 | Form 4 |
| MWA | Helms Todd P | Former Officer/Senior Advisor | 09/01/2026 | Verkauf | 23.67 | 9,997 | 236,593 | Form 4 |
| MRNA | Klinger Shannon Thyme | Chief Legal Officer | 09/01/2026 | Verkauf | 139.95 | 3,471 | 485,766 | Form 4 |
| MIRM | Peetz Christopher | CHIEF EXECUTIVE OFFICER | 09/01/2026 | Verkauf | 98.91 | 21,688 | 2,145,160 | Form 4 |
| MIRM | Peetz Christopher | CHIEF EXECUTIVE OFFICER | 09/01/2026 | Verkauf | 98.08 | 8,312 | 815,241 | Form 4 |
| MAZE | Bernstein Harold | President, R&D & CMO | 09/01/2026 | Verkauf | 26.36 | 16,141 | 425,512 | Form 4 |
| MAZE | Coloma Jason V | Chief Executive Officer | 09/01/2026 | Verkauf | 26.29 | 31,908 | 838,785 | Form 4 |
| MAZE | Coloma Jason V | Chief Executive Officer | 09/01/2026 | Verkauf | 26.31 | 2,593 | 68,214 | Form 4 |
| MTRN | Liggett Emily M | Director | 09/01/2026 | Verkauf | 232.42 | 1,012 | 235,210 | Form 4 |
| MGNI | Buonasera David | CHIEF TECHNOLOGY OFFICER | 09/01/2026 | Verkauf | 23.42 | 5,371 | 125,789 | Form 4 |
| LYFT | Llewellyn Lindsay Catherine | SEE REMARKS | 09/01/2026 | Verkauf | 16.64 | 13,204 | 219,711 | Form 4 |
| LCID | Winitzer Ori | Director | 09/01/2026 | Verkauf | 4.80 | 1,000 | 4,800 | Form 4 |
| LQDA | Krepp Sarah | Chief Human Resource Officer | 09/01/2026 | Verkauf | 67.76 | 274 | 18,566 | Form 4 |
| LIF | Coghlan John Philip | Director | 09/01/2026 | Verkauf | 41.97 | 4,000 | 167,880 | Form 4 |
| LNTH | Lantheus Holdings, Inc. | 10% Owner | 09/01/2026 | Verkauf | 3.12 | 35,769 | 111,574 | Form 4 |
| LAUR | Snow Ian Kendell | Director | 09/01/2026 | Verkauf | 38.11 | 2,654 | 101,157 | Form 4 |
| KNTK | ISQ Global Fund II GP LLC | 10% Owner | 09/01/2026 | Verkauf | 55.06 | 45,428 | 2,501,334 | Form 4 |
| KLTR | Azaria Eynav | See Remarks | 09/01/2026 | Verkauf | 1.54 | 4,328 | 6,677 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).